Interestingly, univariate analysis showed that the evaluation of FOXA1 expression has an important value in the assessment of the prognostic risk for breast cancer patient recurrence, with a magnitude of association similar to the observed for the classical prognostic factors, such as tumour size and lymph node stage, tumour grade, and ER and HER-2 expression. This evidence concerns the gene ERBB2 and breast cancer.